文献速递腹部技术与安全US

一种新技术解决高BMI和脂肪肝患者CEUS成像问题

A Novel Technology for Resolution of CEUS Imaging Problems in Patients With High BMI and Fatty Liver.
PubMed 文献 · J Ultrasound Med · 2023-07-04

本回顾性研究纳入60例患者,评估商用特殊设计超声探头(SDP)在高BMI伴或不伴脂肪肝患者深部扫描中的性能,并与标准凸阵探头比较灰阶和CEUS对肝实质评估及肝脏肿块(重点HCC)表征的能力。结果显示SDP在各级脂肪肝中CEUS穿透力均显著改善(P<.05),在深度>10 cm的恶性肿瘤中改善病灶廓清检测(P<.05),15例深部HCC中SDP诊断93%的LR-5肿瘤,免除了活检需要。

要点

  • SDP在轻度、中度、重度脂肪肝中CEUS穿透力均较标准探头显著改善(P<.05)。
  • 深度>10 cm的恶性肿瘤中,SDP较标准探头改善门静脉期/延迟期病灶廓清检测(P<.05)。
  • 15例确诊深部HCC中,SDP显示动脉期高增强15/15(100%)、PVP/LP廓清14/15(93%),93%的LR-5肿瘤经SDP诊断。

核心结论

  • 代谢综合征和肥胖对超声尤其是CEUS构成挑战,SDP克服了标准探头在脂肪肝中CEUS穿透力的局限,并通过检测廓清成为肝脏肿块表征的最佳选择。

研究设计与样本

  • 回顾性研究,纳入60例患者;55例有BMI测量值,其中46/55(84%)超重或肥胖,9/55(16%)BMI正常但伴重度脂肪肝;56例有局灶性肝脏异常,包括37例肿块和19例消融后治疗部位;肿块包括23例确诊恶性肿瘤(15例HCC、4例ICC、4例转移瘤);SDP在标准探头超声显示欠佳后使用;比较不同脂肪含量图像灰阶穿透深度和CEUS诊断肿瘤能力。

关键影像表现/征象

  • SDP在轻度、中度、重度脂肪肝中CEUS穿透力均较标准探头显著改善(P<.05)。
  • 在深度>10 cm的恶性肿瘤中,SDP较标准探头改善门静脉期/延迟期(PVP/LP)病灶廓清检测(P<.05),在所有恶性肿瘤中亦改善(P<.05)。
  • 15例确诊深部HCC中,标准探头显示动脉期高增强10/15(67%),SDP显示15/15(100%)。
  • 标准探头显示PVP/LP廓清4/15(26%),SDP显示14/15(93%)。

诊断标准与关键数值

  • 15例确诊深部HCC中,SDP诊断93%的LR-5肿瘤,免除了活检需要。
  • 标准探头动脉期高增强10/15(67%)vs SDP 15/15(100%)。
  • 标准探头PVP/LP廓清4/15(26%)vs SDP 14/15(93%)。

临床应用与阅片要点

  • 在高BMI和脂肪肝患者中,当标准探头超声显示欠佳时,可使用SDP进行灰阶和CEUS扫描以改善深部穿透力。
  • SDP有助于检测深度>10 cm恶性肿瘤的PVP/LP廓清,提高HCC等肝脏肿块的表征能力。
  • SDP通过检测廓清使93%的LR-5肿瘤得以诊断,可能免除活检需要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: In high-BMI patients with and without fatty liver, we evaluate performance of a commercially available specially designed ultrasound probe (SDP) for scanning at depth. Greyscale and contrast-enhanced ultrasound (CEUS) capability of SDP for parenchymal assessment and liver mass characterization, emphasizing HCC, is compared with standard curvilinear probes.

METHODS: This retrospective study included 60 patients. Fifty-five with measured BMI included 46/55 (84%) overweight or obese, and 9/55(16%) in the normal range with severe fatty liver. Fifty-six patients with focal liver abnormality included 37 with a mass and 19 with post-ablative treatment site. Masses included 23 confirmed malignancies, 15 HCC, 4 ICC, and 4 metastases. SDP followed suboptimal ultrasound using a standard probe. Images with varying fat content were compared for depth of penetration on greyscale and ability of CEUS to diagnose tumors.

RESULTS: SDP showed statistically significant improvement P = <.05 in CEUS penetration for all degrees of fatty liver (mild, moderate, and severe). In malignant tumors, SDP improved detection of lesion washout in the portal venous/late phase (PVP/LP) at depth >10 cm, and in all malignant masses (P < .05). Fifteen confirmed deep HCC showed arterial phase hyperenhancement on standard probe in 10/15 (67%) and 15/15 (100%) on SDP. PVP/LP washout on standard probe was shown in 4/15 (26%) and on SDP, 14/15, (93%). Therefore, 93% of LR-5 tumors were diagnosed with SDP. Removing necessity for biopsy.

CONCLUSIONS: Metabolic syndrome and obesity challenge ultrasound, especially CEUS. SDP overcame limitations of standard probes for CEUS penetration especially in fatty liver. SDP was optimal for the liver mass characterization by detecting washout.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Merrill, Samuel, Gupta, et al. A Novel Technology for Resolution of CEUS Imaging Problems in Patients With High BMI and Fatty Liver. J Ultrasound Med. 2023. PMID: 37401549. doi:10.1002/jum.16296

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。